According to Amicus Therapeutics 's latest financial reports the company's current earnings are ยฃ0.52 Billion. , an increase over its 2023 earnings that were of -ยฃ0.12 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | -ยฃ22.18 Million | -80.84% |
2023 | -ยฃ0.12 Billion | -37.98% |
2022 | -ยฃ0.19 Billion | 0.2% |
2021 | -ยฃ0.19 Billion | -11.92% |
2020 | -ยฃ0.22 Billion | -22.94% |
2019 | -ยฃ0.28 Billion | 1.95% |
2018 | -ยฃ0.27 Billion | -22.27% |
2017 | -ยฃ0.35 Billion | 120.39% |
2016 | -ยฃ0.16 Billion | 54.24% |
2015 | -ยฃ0.11 Billion | 88.63% |
2014 | -ยฃ54.01 Million | 10.92% |
2013 | -ยฃ48.7 Million | 21.36% |
2012 | -ยฃ40.13 Million | 8.3% |
2011 | -ยฃ37.05 Million | -14.33% |
2010 | -ยฃ43.25 Million | 753.76% |
2009 | -ยฃ5.07 Million | -83.31% |
2008 | -ยฃ30.35 Million | -4.4% |
2007 | -ยฃ31.75 Million |